These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4087205)

  • 1. Comparison of statistical moment parameters to Cmax and tmax for detecting differences in in vivo dissolution rates.
    Khoo KC; Gibaldi M; Brazzell RK
    J Pharm Sci; 1985 Dec; 74(12):1340-2. PubMed ID: 4087205
    [No Abstract]   [Full Text] [Related]  

  • 2. Application of moment analysis in assessing rates of absorption for bioequivalency studies.
    Jackson AJ; Chen ML
    J Pharm Sci; 1987 Jan; 76(1):6-9. PubMed ID: 3585726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time.
    Riegelman S; Collier P
    J Pharmacokinet Biopharm; 1980 Oct; 8(5):509-34. PubMed ID: 7252794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral absorption of poorly water-soluble drugs: computer simulation of fraction absorbed in humans from a miniscale dissolution test.
    Takano R; Sugano K; Higashida A; Hayashi Y; Machida M; Aso Y; Yamashita S
    Pharm Res; 2006 Jun; 23(6):1144-56. PubMed ID: 16715363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico drug absorption tract: An agent-based biomimetic model for human oral drug absorption.
    Deng J; Jhandey A; Zhu X; Yang Z; Yik KFP; Zuo Z; Lam TN
    PLoS One; 2018; 13(8):e0203361. PubMed ID: 30169515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theoretical Investigation of Dissolution Test Criteria for Waiver of Clinical Bioequivalence Study.
    Sugano K
    J Pharm Sci; 2016 Jun; 105(6):1947-1951. PubMed ID: 27238491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Problems in the kinetic evaluation of capacity-limited processes by means of the analog computer MEDA 82 T.
    Franke G; Zschiesche M; Hüller H
    Int J Clin Pharmacol Biopharm; 1978 Sep; 16(9):410-2. PubMed ID: 700913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixing-tank model for predicting dissolution rate control or oral absorption.
    Dressman JB; Fleisher D
    J Pharm Sci; 1986 Feb; 75(2):109-16. PubMed ID: 3958917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro-in vivo correlation, a time scaling problem? Evaluation of mean times.
    Brockmeier D
    Arzneimittelforschung; 1984; 34(11):1604-7. PubMed ID: 6543138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward an increased understanding of the barriers to colonic drug absorption in humans: implications for early controlled release candidate assessment.
    Tannergren C; Bergendal A; Lennernäs H; Abrahamsson B
    Mol Pharm; 2009; 6(1):60-73. PubMed ID: 19183105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro, in Silico, and in Vivo Assessments of Intestinal Precipitation and Its Impact on Bioavailability of a BCS Class 2 Basic Compound.
    Kou D; Zhang C; Yiu H; Ng T; Lubach JW; Janson M; Mao C; Durk M; Chinn L; Winter H; Wigman L; Yehl P
    Mol Pharm; 2018 Apr; 15(4):1607-1617. PubMed ID: 29522347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A reaction limited in vivo dissolution model for the study of drug absorption: Towards a new paradigm for the biopharmaceutic classification of drugs.
    Macheras P; Iliadis A; Melagraki G
    Eur J Pharm Sci; 2018 May; 117():98-106. PubMed ID: 29425862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The method of statistical moments and the integral model-independent parameters of pharmacokinetics].
    Piotrovskiĭ VK
    Farmakol Toksikol; 1986; 49(5):118-27. PubMed ID: 3533616
    [No Abstract]   [Full Text] [Related]  

  • 15. Choice of parameters in pharmacokinetic analysis [proceedings].
    House FR
    Br J Clin Pharmacol; 1979 Apr; 7(4):432P-433P. PubMed ID: 444382
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug absorption during physical exercise.
    Aslaksen A; Aanderud L
    Br J Clin Pharmacol; 1980 Oct; 10(4):383-5. PubMed ID: 7448109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and temperature.
    Ballard BE
    J Pharm Sci; 1974 Sep; 63(9):1345-58. PubMed ID: 4610118
    [No Abstract]   [Full Text] [Related]  

  • 18. An overview of the analysis and interpretation of bioavailability studies in man.
    Wagner JG
    Arzneimittelforschung; 1976; 26(1A):105-8. PubMed ID: 947190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Silico Modeling of Gastrointestinal Drug Absorption: Predictive Performance of Three Physiologically Based Absorption Models.
    Sjögren E; Thörn H; Tannergren C
    Mol Pharm; 2016 Jun; 13(6):1763-78. PubMed ID: 26926043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of rabbits for GI drug absorption studies: relationship between dissolution rate and bioavailability of griseofulvin tablets.
    Maeda T; Takenaka H; Yamahira Y; Noguchi T
    J Pharm Sci; 1979 Oct; 68(10):1286-9. PubMed ID: 512862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.